The estimated Net Worth of Robert K Jr Deveer is at least $107 Mille dollars as of 11 April 2024. Mr. Deveer owns over 6,000 units of Palatin Technologies stock worth over $58,408 and over the last 21 years he sold PTN stock worth over $48,240. In addition, he makes $0 as Independent Director at Palatin Technologies.
Sign up
Mr. deVeer PTN stock SEC Form 4 insiders trading
Robert has made over 9 trades of the Palatin Technologies stock since 2012, according to the Form 4 filled with the SEC. Most recently he bought 6,000 units of PTN stock worth $12,720 on 11 April 2024.
The largest trade he's ever made was buying 54,000 units of Palatin Technologies stock on 18 November 2020 worth over $22,140. On average, Robert trades about 6,726 units every 129 days since 2003. As of 11 April 2024 he still owns at least 40,845 units of Palatin Technologies stock.
You can see the complete history of Mr. Deveer stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Robert deVeer biography
Robert K. deVeer Jr. serves as Independent Director of the Company. He has been a director of Palatin since November 1998. Since January 1997, Mr. deVeer has been the president of deVeer Capital LLC, a private investment company. He was a director of Solutia Inc., a publicly-held chemical-based materials company, until its merger with Eastman Chemical Company in July 2012. From 1995 until his retirement in 1996, Mr. deVeer served as Managing Director, Head of Industrial Group, at New York-based Lehman Brothers. From 1973 to 1995, he held increasingly responsible positions at New York-based CS First Boston, including Head of Project Finance, Head of Industrials and Head of Natural Resources. He was a managing director, member of the investment banking committee and a trustee of the First Boston Foundation. He received a B.A. in economics from Yale University and an M.B.A. in finance from Stanford Graduate School of Business.
How old is Robert deVeer?
Robert deVeer is 74, he's been the Independent Director of Palatin Technologies since 1998. There are no older and 11 younger executives at Palatin Technologies.
What's Robert deVeer's mailing address?
Robert's mailing address filed with the SEC is C/O PALATIN TECHNOLOGIES INC, 4B CEDAR BROOK DRIVE, CRANBURY, NJ, 08512.
Insiders trading at Palatin Technologies
Over the last 22 years, insiders at Palatin Technologies have traded over $3,929,269 worth of Palatin Technologies stock and bought 390,692 units worth $374,235 . The most active insiders traders include Austin W & Greenhouse David..., Partners L P/Ilbiotechnolog... e Carl Spana. On average, Palatin Technologies executives and independent directors trade stock every 76 days with the average trade being worth of $128,497. The most recent stock trade was executed by Stephen T Wills on 1 August 2024, trading 4,999 units of PTN stock currently worth $8,298.
What does Palatin Technologies do?
palatin technologies, inc., a specialized biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the united states. the company's lead product is vyleesi, a melanocortin receptor agonist for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder. it is also developing oral pl8177, a selective melanocortin receptor (mcr) 1 agonist peptide that has completed phase i clinical trial for the treatment of inflammatory bowel diseases; and systemic pl8177, which has completed phase i clinical trial for treating non-infectious uveitis and covid-19. in addition, the company engages in the development of pl9643, a peptide melanocortin agonist active at multiple mcrs, including mc1r and mc5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. further, it is developing pl3994, a natriuretic peptide receptor (npr)-a agonist and sy
What does Palatin Technologies's logo look like?
Complete history of Mr. Deveer stock trades at Palatin Technologies
Palatin Technologies executives and stock owners
Palatin Technologies executives and other stock owners filed with the SEC include:
-
Carl Spana,
President, Chief Executive Officer, Director -
stephen Wills,
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer, Secretary -
Dr. Carl Spana Ph.D.,
Co-Founder, Pres, CEO & Director -
Stephen T. Wills CPA, CPA, MST,
CFO, COO, Exec. VP, Treasurer & Sec. -
Angela Rossetti,
Independent Director -
Arlene Morris,
Independent Director -
Anthony Manning,
Independent Director -
Joseph Hull,
Independent Director -
Alan Dunton,
Independent Director -
Robert deVeer,
Independent Director -
John Prendergast,
Independent Chairman of the Board -
Robert Jordan,
Sr. VP of Program Operations -
John Dodd Ph.D.,
Sr. VP of Preclinical Devel. -
James E. Hattersley,
Sr. VP of Bus. Devel. -
Dr. Michael B. Raizman M.D.,
Chief Medical Officer -
Stephen A. Slusher Esq.,
Chief Legal Officer -
Burns McClellan,
VP of Investor Relations -
Zola P Horovitz,
Director -
Robert I Taber,
Director -
Partners L P/Ilbiotechnolog...,
-
Austin W & Greenhouse David...,
10% owner -
Errol B Desouza,
Director -
Trevor Hallam,
Exec. VP Res. & Dev. -
Perry B Molinoff,
Exec. VP Research and Devel. -
Investments Lpproquest Asso...,
-
Joseph Edelman,
10% owner